ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,702Medicare Part D Prescriptions Filled, Including Refills

Rank: 84 out of 761

$815K Total Retail Price of All Prescriptions

Rank: 27 out of 761

586 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 586 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

16% of this provider’s 586 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 7,707 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 378 287 1 3
LISINOPRIL 356 283 2 1
HYDROCODONE-ACETAMINOPHEN 302 170 S3 3 5
AMLODIPINE BESYLATE 295 227 4 6
OXYCODONE HCL 235 70 S2 5 24
METOPROLOL TARTRATE 233 176 6 14
FUROSEMIDE 213 170 7 7
MORPHINE SULFATE ER 207 77 S2 8 38
HYDROCHLOROTHIAZIDE 190 168 9 11
CRESTOR 184 168 10 36
OMEPRAZOLE 183 151 11 4
LOVASTATIN 171 138 12 17
POTASSIUM CHLORIDE 169 156 13 18
GABAPENTIN 166 94 14 15
SIMVASTATIN 165 135 15 2
OXYCONTIN 163 50 S2 16 114
WARFARIN SODIUM 163 135 16 9
LOSARTAN POTASSIUM 145 120 18 13
METFORMIN HCL 143 107 19 10
GLIMEPIRIDE 139 100 20 48
ZOLPIDEM TARTRATE 138 92 21 22
CITALOPRAM HBR 133 112 22 19
METOPROLOL SUCCINATE 127 77 23 16
NIASPAN 110 86 24 159
DOXAZOSIN MESYLATE 101 95 25 55
ALLOPURINOL 100 74 26 28
DIOVAN 100 90 26 58
ATENOLOL 97 68 28 8
TRAMADOL HCL 95 71 29 34
OXYCODONE-ACETAMINOPHEN 92 66 S2 30 49
ZETIA 91 76 31 87
NAMENDA 89 89 32 59
ATORVASTATIN CALCIUM 87 78 33 12
LANTUS 85 49 34 41
TRAZODONE HCL 85 46 34 23
ACTONEL 85 85 34 171
TAMSULOSIN HCL 84 58 37 27
BENICAR 82 79 38 81
PANTOPRAZOLE SODIUM 81 36 39 40
CLOPIDOGREL 79 52 40 66
SERTRALINE HCL 78 61 41 25
FENTANYL 78 51 S2 41 57
DONEPEZIL HCL 77 68 43 33
CHLORTHALIDONE 74 69 44 89
METHADONE HCL 72 12 S2 45 75
ISOSORBIDE MONONITRATE ER 72 46 45 72
TRIAMTERENE-HYDROCHLOROTHIAZID 63 56 47 68
TRICOR 62 35 48 164
CARVEDILOL 62 62 48 26
CYCLOBENZAPRINE HCL 61 19 R 50 51
AMITRIPTYLINE HCL 60 40 R 51 54
PRAVASTATIN SODIUM 57 53 52 20
QUINAPRIL HCL 56 56 53 156
SPIRIVA 55 46 54 56
DILTIAZEM 24HR ER 53 33 55 190
AZITHROMYCIN 52 38 56 70
PROAIR HFA 51 44 57 32
VENTOLIN HFA 50 34 58 111
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.